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Introduction
Here we describe a new genetic disease characterized by
fevers and systemic inflammation, livedo reticularis, mild
immunodeficiency, and early-onset recurrent lacunar
strokes in 5 unrelated patients.
Objectives
To identify a possible genetic cause of this syndrome.
Methods
We used a combination of exome and Sanger sequen-
cing, SNP arrays, Western blots (WB), ELISA assays,
radiochemical-thin layer chromatography, and HPLC.
Results
The 5 unrelated patients shared 3 missense mutations in
CECR1, encoding adenosine deaminase 2 (ADA2), with
the genotypes A109D/Y453C, Y453C/G47A, G47A/
H112Q, R169Q/Y453C, and R169Q/28kb genomic dele-
tion encompassing the 5’UTR and first exon of CECR1.
All of the mutations are either novel or present at low
frequency (<0.001) in several large databases. Computer
modeling based on the crystal structure of the human
ADA2 protein suggests that CECR1 mutations either
disrupt protein stability or impair ADA2 enzyme activity.
Whereas the ADA1 protein, which is mutated in some
patients with severe combined immunodeficiency disease,
is an intracellular protein that catalyzes the conversion of
adenosine to inosine, ADA2 is expressed predominantly in
myeloid cells and secreted into the blood, and has a lower
affinity for adenosine than ADA1. Western blots showed a
decrease in ADA2 protein in supernatants of PBMCs from
patients relative to healthy controls. All patients had at
least 10-fold diminished serum and plasma concentrations
of ADA2 protein, and reduced ADA2-specific adenosine
deaminase activity. However, whereas ADA1 deficiency
leads to the accumulation of deoxyadenosine nucleotides
and lymphocytotoxicity, such toxic metabolites were not
found in the blood of patients with ADA2 deficiency.
Animal models suggest that ADA2 is the prototype for a
family of proteins with growth factor activity (adenosine
deaminase growth factors, ADGF). There is no mouse
homolog of CECR1, but there are 2 homologs in the
zebrafish, Cecr1a and Cecr1b. While a zebrafish line with a
hypomorphic retroviral insertion in Cecr1a did not exhibit
an obvious phenotype, when we used 2 different morpho-
linos to knock down the expression of Cecr1b, at 48 hours
post fertilization we observed intracranial hemorrhage in
approximately 50% of zebrafish embryos, but in only 3% of
control embryos. Utilizing zebrafish lines with GFP-tagged
leukocytes, we found that Cecr1b knockdown also led to
the near absence of neutrophils, but not monocytes. These
observations suggest that the ADA2 homolog may
be necessary both for vascular integrity and leukocyte
development in the zebrafish, and that the near absence of
ADA2 in humans may lead to strokes and autoinflamma-
tion by similar mechanisms.
Conclusion
We propose the term fever with early onset stroke (FEOS)
to denote this condition. Although it is a rare disease of
children, FEOS may provide important insights into the
role of ADGFs in human disease, and may elucidate novel
pathways underlying strokes in adults.
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